Citations (130)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Jialiang Duan, Yang Wang, Danyan Liu & Jingxue Ma. (2019) Induction of Vogt-Koyanagi-Harada Disease by Interferon-Alpha and Ribavirin Treatment in Patients with Hepatitis C: A Case Report and Review of the Literature. Ocular Immunology and Inflammation 27:2, pages 229-234.
Read now
Read now
Hagime Kaga, Atsushi Komatsuda, Ayumi Omokawa, Mitsugu Ito, Kazuaki Teshima, Hiroyuki Tagawa, Kenichi Sawada & Hideki Wakui. (2015) Downregulated expression of miR-155, miR-17, and miR-181b, and upregulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE. Modern Rheumatology 25:6, pages 865-870.
Read now
Read now
Andreas P. Diamantopoulos, Helene Hetland, Atle E. Hansen & Geirmund Myklebust. (2012) Severe deterioration of newly diagnosed Takayasu arteritis in a patient re-treated with interferon beta-1α for concomitant longstanding multiple sclerosis. Modern Rheumatology 22:3, pages 474-478.
Read now
Read now
Martina Biggioggero, Lisa Gabbriellini & Pier Luigi Meroni. (2010) Type I interferon therapy and its role in autoimmunity. Autoimmunity 43:3, pages 248-254.
Read now
Read now
Donna L Thibault Flesher, Xin Sun, Timothy W Behrens, Robert R Graham & Lindsey A Criswell. (2010) Recent advances in the genetics of systemic lupus erythematosus. Expert Review of Clinical Immunology 6:3, pages 461-479.
Read now
Read now
Laura M Burdick, Najwa Somani & Ally-Khan Somani. (2009) Type I IFNs and their role in the development of autoimmune diseases. Expert Opinion on Drug Safety 8:4, pages 459-472.
Read now
Read now
Articles from other publishers (124)
Mariam G. Abdelmonem, Manal A. Mohammed, Hosam Abdel Twab & Eman B. Elmarghany. (2023) Serum level of galectin-9 in systemic lupus erythematosus patients with lupus nephritis: Relation to clinical characteristics and disease activity. The Egyptian Rheumatologist 45:4, pages 294-298.
Crossref
Crossref
Zhipeng Zeng, Wei Tu, Bai Ji, Jie Liu, Kecheng Huang, Daan Nie & Liu Yang. (2023) IFN-α induced systemic lupus erythematosus complicated with hemophagocytic lymphohistiocytosis: a case report and literature review. Frontiers in Immunology 14.
Crossref
Crossref
Maria R. Jimenez-Leon, Carmen Gasca-Capote, Laura Tarancon-Diez, Beatriz Dominguez-Molina, Macarena Lopez-Verdugo, Ryan Ritraj, Isabel Gallego, Ana I. Alvarez-Rios, Joana Vitalle, Sara Bachiller, María Inés Camacho-Sojo, Alberto Perez-Gomez, Nuria Espinosa, Cristina Roca-Oporto, Mohamed Rafii-El-Idrissi Benhnia, Alicia Gutierrez-Valencia, Luis F. Lopez-Cortes & Ezequiel Ruiz-Mateos. (2023) Toll-like receptor agonists enhance HIV-specific T cell response mediated by plasmacytoid dendritic cells in diverse HIV-1 disease progression phenotypes. eBioMedicine 91, pages 104549.
Crossref
Crossref
Shangran Zhang, Runan Zheng, Yanhong Pan & Hongbin Sun. (2023) Potential Therapeutic Value of the STING Inhibitors. Molecules 28:7, pages 3127.
Crossref
Crossref
Daniele Accapezzato, Rosalba Caccavale, Maria Pia Paroli, Chiara Gioia, Bich Lien Nguyen, Luca Spadea & Marino Paroli. (2023) Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus. International Journal of Molecular Sciences 24:7, pages 6578.
Crossref
Crossref
Noura Alforaih, Laura Whittall-Garcia & Zahi Touma. (2022) A Review of Lupus Nephritis. The Journal of Applied Laboratory Medicine 7:6, pages 1450-1467.
Crossref
Crossref
Shu-Ming Chou, Hsing-Jung Yeh, Tzu-Min Lin, Yu-Sheng Chang, Hui-Ching Hsu, Yu-Chuan Shen, Tzu-Tung Kuo, Jin-Hua Chen, Shu-Chuan Chen & Chi-Ching Chang. (2022) Association of interferon-based therapy with risk of autoimmune diseases in patients with chronic hepatitis C virus infection: A population-based Taiwanese cohort study. Frontiers in Immunology 13.
Crossref
Crossref
Yifei Zhao, Ke Zhao, Shaohua Wang & Juan Du. (2022) Multi-functional BST2/tetherin against HIV-1, other viruses and LINE-1. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Julián Torres-Vázquez, Martín Uriel Vázquez-Medina, David Alberto Comoto-Santacruz, Mariano Emilio Pradillo-Macias, Omar Eloy Muñoz-Monroy & Adriana Martínez-Cuazitl. (2022) Relationship of IP-10 gene expression to systemic lupus erythematosus activity. Reumatología Clínica (English Edition) 18:2, pages 91-93.
Crossref
Crossref
Julián Torres-Vázquez, Martín Uriel Vázquez-Medina, David Alberto Comoto-Santacruz, Mariano Emilio Pradillo-Macias, Omar Eloy Muñoz-Monroy & Adriana Martínez-Cuazitl. (2022) Relación de la expresión génica de IP-10 con la actividad del lupus eritematoso sistémico. Reumatología Clínica 18:2, pages 91-93.
Crossref
Crossref
Luis Ramos Ruperto, Carmen Busca Arenzana, Angel Robles Marhuenda & Jose I. Bernardino. 2022. Translational Autoimmunity. Translational Autoimmunity
141
167
.
Sirisha Sirobhushanam, Stephanie Lazar & J. Michelle Kahlenberg. (2021) Interferons in Systemic Lupus Erythematosus. Rheumatic Disease Clinics of North America 47:3, pages 297-315.
Crossref
Crossref
Wenyu Xu, Yueyue Zhang, Xiaoqin Wang, Peiyu Liu, Dayu Gao, Bingjie Gu, Junyu Zhang, Chunmei Li, Qijie Ren, Leilei Yang, Hai Yuan, Minning Shen & Xingguo Chen. (2020) Clinical features and expression of type I interferon-inducible genes in systemic lupus erythematosus patients harboring rs1143679 polymorphism in China: a single-center, retrospective study. Clinical Rheumatology 40:3, pages 1093-1101.
Crossref
Crossref
Fotios Koumpouras & Richard Bucala. 2021. Lahita's Systemic Lupus Erythematosus. Lahita's Systemic Lupus Erythematosus
169
180
.
Sebastian Bruera & Cerena K. Leung. 2021. Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy. Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy
255
269
.
Samah M. Alian, Mohamed Othman Wahba, Ahmed Fathy Gomaa & Sahar S. Khalil. (2020) The efficacy and safety of direct-acting antiviral drugs in the management of hepatitis C virus-related arthritis. Egyptian Rheumatology and Rehabilitation 47:1.
Crossref
Crossref
Hung-Jen Chen, Sander W. Tas & Menno P.J. de Winther. (2020) Type-I interferons in atherosclerosis. Journal of Experimental Medicine 217:1.
Crossref
Crossref
Kathryn A. Wierenga, Jack R. Harkema & James J. Pestka. (2019) Lupus, Silica, and Dietary Omega-3 Fatty Acid Interventions. Toxicologic Pathology 47:8, pages 1004-1011.
Crossref
Crossref
Ritudhwaj TiwariJuan C. de la TorreDorian B. McGavernDebasis Nayak. (2019)
Beyond Tethering the Viral Particles: Immunomodulatory Functions of Tetherin (
BST-2
)
. DNA and Cell Biology 38:11, pages 1170-1177.
Crossref
Crossref
Pongpratch Puapatanakul, Sonchai Chansritrakul, Paweena Susantitaphong, Thornthun Ueaphongsukkit, Somchai Eiam-Ong, Kearkiat Praditpornsilpa, Wonngarm Kittanamongkolchai & Yingyos Avihingsanon. (2019) Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences 20:19, pages 4954.
Crossref
Crossref
Anna Elisa Andrea Surace & Christian M. Hedrich. (2019) The Role of Epigenetics in Autoimmune/Inflammatory Disease. Frontiers in Immunology 10.
Crossref
Crossref
Sasha Silva‐Barrios & Simona Stäger. (2019)
Hypergammaglobulinemia sustains the development of regulatory responses during chronic
Leishmania donovani
infection in mice
. European Journal of Immunology 49:7, pages 1082-1091.
Crossref
Crossref
Patrice Cacoub, Si Nafa Si Ahmed, Yasmina Ferfar, Stanislas Pol, Dominique Thabut, Christophe Hezode, Laurent Alric, Cloe Comarmond, Gafaar Ragab, Luca Quartuccio, Mohamed Hegazy, Thierry Poynard, Matthieu Resche Rigon & David Saadoun. (2019) Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus–Associated Cryoglobulinemia Vasculitis. Clinical Gastroenterology and Hepatology 17:3, pages 518-526.
Crossref
Crossref
Bruce C. Richardson. 2019. Dubois' Lupus Erythematosus and Related Syndromes. Dubois' Lupus Erythematosus and Related Syndromes
377
388
.
Mary K. Crow, Kyriakos A. Kirou & Timothy B. Niewold. 2019. Dubois' Lupus Erythematosus and Related Syndromes. Dubois' Lupus Erythematosus and Related Syndromes
137
152
.
Rambon Shamilov & Brian J. Aneskievich. (2018) TNIP1 in Autoimmune Diseases: Regulation of Toll-like Receptor Signaling. Journal of Immunology Research 2018, pages 1-13.
Crossref
Crossref
Yasuhiro Kato, JeongHoon Park, Hyota Takamatsu, Hachirou Konaka, Wataru Aoki, Syunsuke Aburaya, Mitsuyoshi Ueda, Masayuki Nishide, Shohei Koyama, Yoshitomo Hayama, Yuhei Kinehara, Toru Hirano, Yoshihito Shima, Masashi Narazaki & Atsushi Kumanogoh. (2018) Apoptosis-derived membrane vesicles drive the cGAS–STING pathway and enhance type I IFN production in systemic lupus erythematosus. Annals of the Rheumatic Diseases 77:10, pages 1507-1515.
Crossref
Crossref
Kathleen E. Sullivan. (2018) Pathogenesis of Pediatric Rheumatologic Diseases. Pediatric Clinics of North America 65:4, pages 639-655.
Crossref
Crossref
Cynthia Louis, Chris Burns & Ian Wicks. (2018) TANK-Binding Kinase 1-Dependent Responses in Health and Autoimmunity. Frontiers in Immunology 9.
Crossref
Crossref
Cécile Picard & Alexandre Belot. (2017) Does type-I interferon drive systemic autoimmunity?. Autoimmunity Reviews 16:9, pages 897-902.
Crossref
Crossref
Hirotsugu Oda & Daniel L. Kastner. (2017) Genomics, Biology, and Human Illness. Rheumatic Disease Clinics of North America 43:3, pages 327-345.
Crossref
Crossref
David Saadoun & Patrice Cacoub. (2017) Response to: Cryoglobulinemic vasculitis in the era of direct-acting antiviral drug. Annals of the Rheumatic Diseases 76:3, pages e6.
Crossref
Crossref
Cristina Arriens, Jonathan D. Wren, Melissa E. Munroe & Chandra Mohan. (2016) Systemic lupus erythematosus biomarkers: the challenging quest. Rheumatology, pages kew407.
Crossref
Crossref
Ming Zhao, Yin Zhou, Bochen Zhu, Mengjie Wan, Tingting Jiang, Qiqun Tan, Yan Liu, Juqing Jiang, Shuaihantian Luo, Yixin Tan, Haijing Wu, Paul Renauer, Maria del Mar Ayala Gutiérrez, Maria Jesús Castillo Palma, Rafaela Ortega Castro, Concepción Fernández-Roldán, Enrique Raya, Raquel Faria, Claudia Carvalho, Marta E Alarcón-Riquelme, Zhongyuan Xiang, Jinwei Chen, Fen Li, Guanghui Ling, Hongjun Zhao, Xiangping Liao, Youkun Lin, Amr H Sawalha & Qianjin Lu. (2016)
IFI44L
promoter methylation as a blood biomarker for systemic lupus erythematosus
. Annals of the Rheumatic Diseases 75:11, pages 1998-2006.
Crossref
Crossref
David Saadoun, Vincent Thibault, Si Nafa Si Ahmed, Laurent Alric, Maxime Mallet, Constance Guillaud, Hassane Izzedine, Aurélie Plaisier, Hélène Fontaine, Myrto Costopoulos, Magali Le Garff-Tavernier, Christophe Hezode, Stanislas Pol, Lucile Musset, Thierry Poynard & Patrice Cacoub. (2016) Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study. Annals of the Rheumatic Diseases 75:10, pages 1777-1782.
Crossref
Crossref
Michelle Willicombe, Jill Moss, Linda Moran, Paul Brookes, Eva Santos-Nunez, Adam G. McLean, Thomas Cairns, David Taube, Terence H. Cook & Candice Roufosse. (2016) Tubuloreticular Inclusions in Renal Allografts Associate with Viral Infections and Donor-Specific Antibodies. Journal of the American Society of Nephrology 27:7, pages 2188-2195.
Crossref
Crossref
Sasha Silva-Barrios, Mélina Smans, Claudia U. Duerr, Salman T. Qureshi, Jörg H. Fritz, Albert Descoteaux & Simona Stäger. (2016) Innate Immune B Cell Activation by Leishmania donovani Exacerbates Disease and Mediates Hypergammaglobulinemia. Cell Reports 15:11, pages 2427-2437.
Crossref
Crossref
C.E. Wobus, J.B. Cunha, M.D. Elftman & A.O. Kolawole. 2016. Viral Gastroenteritis. Viral Gastroenteritis
397
422
.
Jyoti Bakshi, Mediola Ismajli & Anisur Rahman. (2015) New therapeutic avenues in SLE. Best Practice & Research Clinical Rheumatology 29:6, pages 794-809.
Crossref
Crossref
Georg Lorenz & Hans-Joachim Anders. (2015) Neutrophils, Dendritic Cells, Toll-Like Receptors, and Interferon-α in Lupus Nephritis. Seminars in Nephrology 35:5, pages 410-426.
Crossref
Crossref
Namir Shaabani, Nadine Honke, Sebastian Dolff, Boris Görg, Vishal Khairnar, Katja Merches, Vikas Duhan, Sabine Metzger, Mike Recher, Carmen Barthuber, Cornelia Hardt, Peter Proksch, Dieter Häussinger, Oliver Witzke, Philipp A. Lang & Karl S. Lang. (2015) IFN-γ licenses CD11b+ cells to induce progression of systemic lupus erythematosus. Journal of Autoimmunity 62, pages 11-21.
Crossref
Crossref
Shivani Srivastava, Lisa K. Koch & Daniel J. Campbell. (2014) IFNαR Signaling in Effector but Not Regulatory T Cells Is Required for Immune Dysregulation during Type I IFN–Dependent Inflammatory Disease. The Journal of Immunology 193:6, pages 2733-2742.
Crossref
Crossref
Mary K. Crow. (2014) Type I Interferon in the Pathogenesis of Lupus. The Journal of Immunology 192:12, pages 5459-5468.
Crossref
Crossref
Philipp Haselmayer, Montserrat Camps, Mathilde Muzerelle, Samer El Bawab, Caroline Waltzinger, Lisa Bruns, Nada Abla, Mark A. Polokoff, Carole Jond-Necand, Marilène Gaudet, Audrey Benoit, Dominique Bertschy Meier, Catherine Martin, Denise Gretener, Maria Stella Lombardi, Roland Grenningloh, Christoph Ladel, Jørgen Søberg Petersen, Pascale Gaillard & Hong Ji. (2014) Characterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies. Frontiers in Immunology 5.
Crossref
Crossref
C. Yuste, M. Rapalai, B. A. Pritchard, T. J. Jones, B. Tucker & S. B. Ramakrishna. (2014) Nephrotic-range proteinuria on interferon- treatment: immune-induced glomerulonephritis or other pathway?. Clinical Kidney Journal 7:2, pages 190-193.
Crossref
Crossref
F Kanakoudi-Tsakalidou, E Farmaki, V Tzimouli, A Taparkou, G Paterakis, M Trachana, P Pratsidou-Gertsi, P Nalbanti & F Papachristou. (2014) Simultaneous changes in serum HMGB1 and IFN-α levels and in LAIR-1 expression on plasmatoid dendritic cells of patients with juvenile SLE.. New therapeutic options?. Lupus 23:3, pages 305-312.
Crossref
Crossref
E. Christophers, G. Metzler & M. Röcken. (2014) Bimodal immune activation in psoriasis. British Journal of Dermatology 170:1, pages 59-65.
Crossref
Crossref
Ann Marshak-Rothstein & Michael P. Cancro. 2014. Biological DNA Sensor. Biological DNA Sensor
133
152
.
Surya Pandey & Taro Kawai. 2014. Biological DNA Sensor. Biological DNA Sensor
103
132
.
Cristina Arriens & Chandra Mohan. (2013) Systemic lupus erythematosus diagnostics in the ‘omics’ era. International Journal of Clinical Rheumatology 8:6, pages 671-687.
Crossref
Crossref
Aejaz Sayeed, Gloria Luciani-Torres, Zhenhang Meng, James L. Bennington, Dan H. Moore & Shanaz H. Dairkee. (2013) Aberrant Regulation of the BST2 (Tetherin) Promoter Enhances Cell Proliferation and Apoptosis Evasion in High Grade Breast Cancer Cells. PLoS ONE 8:6, pages e67191.
Crossref
Crossref
Chin-Nien Lee, Andrew M Lew & Li Wu. (2013) The potential role of dendritic cells in the therapy of Type 1 diabetes. Immunotherapy 5:6, pages 591-606.
Crossref
Crossref
Shinichi Imafuku & Juichiro Nakayama. (2013)
Profile of patients with psoriasis associated with hepatitis
C
virus infection
. The Journal of Dermatology 40:6, pages 428-433.
Crossref
Crossref
Manuel Wallbach, Herman J. Gröne, Bernd Kitze, Gerhard A. Müller & Michael J. Koziolek. (2013) Nephrotic Syndrome in a Multiple Sclerosis Patient Receiving Long-term Interferon Beta Therapy. American Journal of Kidney Diseases 61:5, pages 786-789.
Crossref
Crossref
Dipak Patel & Bruce Richardson. 2013. Dubois' Lupus Erythematosus and Related Syndromes. Dubois' Lupus Erythematosus and Related Syndromes
484
494
.
Mary K. Crow, Timothy B. Niewold & Kyriakos A. Kirou. 2013. Dubois' Lupus Erythematosus and Related Syndromes. Dubois' Lupus Erythematosus and Related Syndromes
62
75
.
Jacqueline M. McBride, Jenny Jiang, Alexander R. Abbas, Alyssa Morimoto, Jing Li, Romeo Maciuca, Michael Townsend, Daniel J. Wallace, William P. Kennedy & Jorn Drappa. (2012) Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: Results of a phase I, placebo‐controlled, double‐blind, dose‐escalation study. Arthritis & Rheumatism 64:11, pages 3666-3676.
Crossref
Crossref
Atsushi Ogata, Atsushi Kumanogoh & Toshio Tanaka. (2012) Pathological Role of Interleukin-6 in Psoriatic Arthritis. Arthritis 2012, pages 1-6.
Crossref
Crossref
Kerstin Kiefer, Michael A Oropallo, Michael P Cancro & Ann Marshak‐Rothstein. (2012) Role of type I interferons in the activation of autoreactive B cells. Immunology & Cell Biology 90:5, pages 498-504.
Crossref
Crossref
Mariana G. Bego, Johanne Mercier & Éric A. Cohen. (2012)
Virus-Activated Interferon Regulatory Factor 7 Upregulates Expression of the Interferon-Regulated
BST2
Gene Independently of Interferon Signaling
. Journal of Virology 86:7, pages 3513-3527.
Crossref
Crossref
Chun-yan Ma, Yu-lian Jiao, Jie Zhang, Qing-rui Yang, Zhi-fen Zhang, Ya-juan Shen, Zi-jiang Chen & Yue-ran Zhao. (2010) Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-alpha and TNF-alpha in systemic lupus erythematosus. Rheumatology International 32:2, pages 395-402.
Crossref
Crossref
Alberto de Zubiria Salgado & Catalina Herrera-Diaz. (2012) Lupus Nephritis: An Overview of Recent Findings. Autoimmune Diseases 2012, pages 1-21.
Crossref
Crossref
Shinji Maeda, Yoshihito Hayami, Taio Naniwa & Ryuzo Ueda. (2012) The Th17/IL-23 Axis and Natural Immunity in Psoriatic Arthritis. International Journal of Rheumatology 2012, pages 1-8.
Crossref
Crossref
Timothy B. Niewold. (2011) Interferon Alpha as a Primary Pathogenic Factor in Human Lupus. Journal of Interferon & Cytokine Research 31:12, pages 887-892.
Crossref
Crossref
Naoya MIKITA, Takaharu IKEDA, Mariko ISHIGURO & Fukumi FURUKAWA. (2011) Recent advances in cytokines in cutaneous and systemic lupus erythematosus. The Journal of Dermatology, pages no-no.
Crossref
Crossref
Michelle M. A. Fernando, Adam J. de Smith, Lachlan Coin, David L. Morris, Philippe Froguel, Jonathan Mangion, Alexandra I. F. Blakemore, Robert R. Graham, Timothy W. Behrens & Timothy J. Vyse. (2011) Investigation of the HIN200 Locus in UK SLE Families Identifies Novel Copy Number Variants. Annals of Human Genetics 75:3, pages 383-397.
Crossref
Crossref
Mary K. Crow. 2011. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus
307
320
.
P Lenert. (2010) Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus. Clinical and Experimental Immunology 161:2, pages 208-222.
Crossref
Crossref
Anne Amherd-Hoekstra, Helmut Näher, Hanns-Martin Lorenz & Alexander H. Enk. (2009) Psoriatic arthritis: a review. Journal der Deutschen Dermatologischen Gesellschaft 8:5, pages 332-339.
Crossref
Crossref
Rong Zhang, Meifen Xing, Xiaohui Ji, Lei Gu, Xiaofan Yang, Huijuan Wang & Pengtao Jiang. (2010) Interferon-α and Interleukin-6 in SLE serum induce the differentiation and maturation of dendritic cells derived from CD34+ hematopoietic precursor cells. Cytokine 50:2, pages 195-203.
Crossref
Crossref
Michael G. Tovey & Christophe Lallemand. (2010) Safety, Tolerability, and Immunogenicity of Interferons. Pharmaceuticals 3:4, pages 1162-1186.
Crossref
Crossref
Wei Cao & Laura Bover. (2010) Signaling and ligand interaction of ILT7: receptor‐mediated regulatory mechanisms for plasmacytoid dendritic cells. Immunological Reviews 234:1, pages 163-176.
Crossref
Crossref
S Imafuku & J Nakayama. (2010) Questionnaire-based survey of the treatment of patients with psoriasis and hepatitis C in Japan. Journal of the European Academy of Dermatology and Venereology.
Crossref
Crossref
Angélica M Delgado-Vega, Marta E Alarcón-Riquelme & Sergey V Kozyrev. (2010) Genetic associations in type I interferon related pathways with autoimmunity. Arthritis Research & Therapy 12:Suppl 1, pages S2.
Crossref
Crossref
George D Kalliolias & Lionel B Ivashkiv. (2010) Overview of the biology of type I interferons. Arthritis Research & Therapy 12:Suppl 1, pages S1.
Crossref
Crossref
Timothy B. Niewold, Daniel N. Clark, Rafah Salloum & Brian D. Poole. (2010) Interferon Alpha in Systemic Lupus Erythematosus. Journal of Biomedicine and Biotechnology 2010, pages 1-8.
Crossref
Crossref
Yi‐chi M. Kong, Wei‐Zen Wei & Yaron Tomer. (2010) Opportunistic autoimmune disorders. Annals of the New York Academy of Sciences 1183:1, pages 222-236.
Crossref
Crossref
N Roescher, PP Tak & GG Illei. (2009) Cytokines in Sjögren’s syndrome. Oral Diseases 15:8, pages 519-526.
Crossref
Crossref
Armin G. Jegalian, Fabio Facchetti & Elaine S. Jaffe. (2009) Plasmacytoid Dendritic Cells. Advances in Anatomic Pathology 16:6, pages 392-404.
Crossref
Crossref
Rong Zhang, Meifen Xing, Weiwen Wang, Xiaofan Yang & Xiaohui Ji. (2009) Effect of Interferon-alpha in systemic lupus erthematosus (SLE) serum on the differentiation and maturation of dendritic cells derived from CD34+ hematopoietic precursor cells. Journal of Nanjing Medical University 23:6, pages 380-385.
Crossref
Crossref
M Petri, S Singh, H Tesfasyone, R Dedrick, K Fry, PG Lal, G Williams, JW Bauer, PK Gregersen, TW Behrens & EC Baechler. (2009) Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus. Lupus 18:11, pages 980-989.
Crossref
Crossref
Nathaniel M. Green, Amy Laws, Kerstin Kiefer, Liliana Busconi, You-Me Kim, Melanie M. Brinkmann, Erin Hodges Trail, Kei Yasuda, Sean R. Christensen, Mark J. Shlomchik, Stefanie Vogel, John H. Connor, Hidde Ploegh, Dan Eilat, Ian R. Rifkin, Jean Maguire van Seventer & Ann Marshak-Rothstein. (2009) Murine B Cell Response to TLR7 Ligands Depends on an IFN-β Feedback Loop. The Journal of Immunology 183:3, pages 1569-1576.
Crossref
Crossref
Wei Cao, Laura Bover, Minkwon Cho, Xiaoxia Wen, Shino Hanabuchi, Musheng Bao, David B. Rosen, Yi-Hong Wang, Joanne L. Shaw, Qiumei Du, Chun Li, Naoko Arai, Zhengbin Yao, Lewis L. Lanier & Yong-Jun Liu. (2009) Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. Journal of Experimental Medicine 206:7, pages 1603-1614.
Crossref
Crossref
Bahram Namjou, Andrea L. Sestak, Don L. Armstrong, Raphael Zidovetzki, Jennifer A. Kelly, Noam Jacob, Voicu Ciobanu, Kenneth M. Kaufman, Joshua O. Ojwang, Julie Ziegler, Francesco P. QuismorioJr.Jr., Andreas Reiff, Barry L. Myones, Joel M. Guthridge, Swapan K. Nath, Gail R. Bruner, Ruth Mehrian-Shai, Earl Silverman, Marisa Klein-Gitelman, Deborah McCurdy, Linda Wagner-Weiner, James J. Nocton, Chaim Putterman, Sang-Cheol Bae, Yun Jung Kim, Michelle Petri, John D. Reveille, Timothy J. Vyse, Gary S. Gilkeson, Diane L. Kamen, Marta E. Alarcón-Riquelme, Patrick M. Gaffney, Kathy L. Moser, Joan T. Merrill, R. Hal Scofield, Judith A. James, Carl D. Langefeld, John B. Harley & Chaim O. Jacob. (2009) High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Arthritis & Rheumatism 60:4, pages 1085-1095.
Crossref
Crossref
Brian J. Scaglione, Erica Salerno, Kinisha Gala, Manjing Pan, Jerome A. Langer, Howard S. Mostowski, Steven Bauer, Gerald Marti, Yu Li, Vincent K. Tsiagbe & Elizabeth S. Raveche. (2009) Regulatory T cells as central regulators of both autoimmunity and B cell malignancy in New Zealand Black mice. Journal of Autoimmunity 32:1, pages 14-23.
Crossref
Crossref
Guido Poggi, Laura Villani, Federico Sottotetti, Barbara Tagliaferri, Benedetta Montagna, Alessio Amatu & Giovanni Bernardo. (2009) Treatment of Chronic Hepatitis C in a Patient Affected by Systemic Sclerosis. Gastroenterology Research and Practice 2009, pages 1-5.
Crossref
Crossref
Wan-Uk Kim, Antoine Sreih & Richard Bucala. (2009) Toll-like receptors in systemic lupus erythematosus; prospects for therapeutic intervention. Autoimmunity Reviews 8:3, pages 204-208.
Crossref
Crossref
Bartosz Chmielowski & Antoni Ribas. 2009. From Local Invasion to Metastatic Cancer. From Local Invasion to Metastatic Cancer
575
590
.
Judith Field, Frank Alderuccio, Paul Hertzog & Ban-Hock Toh. (2008) GM-CSF-induced autoimmune gastritis in interferon α receptor deficient mice. Journal of Autoimmunity 31:3, pages 274-280.
Crossref
Crossref
Bettina Wagner, Julie M. Hillegas, M. Julia B.F. Flaminio & Eva Wattrang. (2008) Monoclonal antibodies to equine interferon-α (IFN-α): New tools to neutralize IFN-activity and to detect secreted IFN-α. Veterinary Immunology and Immunopathology 125:3-4, pages 315-325.
Crossref
Crossref
Patrice Cacoub & David Saadoun. (2008) Hepatitis C Virus Infection Induced Vasculitis. Clinical Reviews in Allergy & Immunology 35:1-2, pages 30-39.
Crossref
Crossref
A Meager, P Peterson & N Willcox. (2008) Hypothetical review: thymic aberrations and type-I interferons; attempts to deduce autoimmunizing mechanisms from unexpected clues in monogenic and paraneoplastic syndromes. Clinical and Experimental Immunology 154:1, pages 141-151.
Crossref
Crossref
Tomoko Okamoto, Masafumi Ogawa, Youwei Lin, Miho Murata, Sachiko Miyake & Takashi Yamamura. (2008) Review: Treatment of neuromyelitis optica: Current debate. Therapeutic Advances in Neurological Disorders 1:1, pages 43-52.
Crossref
Crossref
Manon E. Wildenberg, Cornelia G. van Helden‐Meeuwsen, Joop P. van de Merwe, Hemmo A. Drexhage & Marjan A. Versnel. (2008) Systemic increase in type I interferon activity in Sjögren's syndrome: A putative role for plasmacytoid dendritic cells. European Journal of Immunology 38:7, pages 2024-2033.
Crossref
Crossref
Seetha U Monrad, Karl C Desch & Mariana J Kaplan. (2008) Role of dendritic cells in the pathogenesis of systemic lupus erythematosus. Future Rheumatology 3:3, pages 269-279.
Crossref
Crossref
Timothy B. Niewold. (2008) Interferon Alpha-Induced Lupus. JCR: Journal of Clinical Rheumatology 14:3, pages 131-132.
Crossref
Crossref
Takahiro Sugiyama, Katsuaki Hoshino & Tsuneyasu Kaisho. 2008. Nucleic Acids in Innate Immunity. Nucleic Acids in Innate Immunity
43
58
.
A Komatsuda, H Wakui, K Iwamoto, M Ozawa, M Togashi, R Masai, N Maki, T Hatakeyama & K Sawada. (2008) Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clinical and Experimental Immunology 152:3, pages 482-487.
Crossref
Crossref
Mieke F. Roelofs, Shahla Abdollahi-Roodsaz, Leo A. B. Joosten, Wim B. van den Berg & Timothy R. D. J. Radstake. (2008) The orchestra of toll-like receptors and their potential role in frequently occurring rheumatic conditions. Arthritis & Rheumatism 58:2, pages 338-348.
Crossref
Crossref
David Saadoun, Aurelien Delluc, Jean Charles Piette & Patrice Cacoub. (2008) Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis. Current Opinion in Rheumatology 20:1, pages 23-28.
Crossref
Crossref
Karl S. Lang, Annika Burow, Michael Kurrer, Philipp A. Lang & Mike Recher. (2007) The role of the innate immune response in autoimmune disease. Journal of Autoimmunity 29:4, pages 206-212.
Crossref
Crossref
C Kyogoku & N Tsuchiya. (2007) A compass that points to lupus: genetic studies on type I interferon pathway. Genes & Immunity 8:6, pages 445-455.
Crossref
Crossref
David Saadoun, Jean‐Charles Piette & Patrice Cacoub. (2007) Reply. Arthritis & Rheumatism 56:8, pages 2810-2811.
Crossref
Crossref
Snaevar Sigurdsson, Leonid Padyukov, Fina A. S. Kurreeman, Ulrika Liljedahl, Ann‐Christin Wiman, Lars Alfredsson, René Toes, Johan Rönnelid, Lars Klareskog, Tom W. J. Huizinga, Gunnar Alm, Ann‐Christine Syvänen & Lars Rönnblom. (2007) Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis & Rheumatism 56:7, pages 2202-2210.
Crossref
Crossref
Seetha Monrad & Mariana J. Kaplan. (2007) Dendritic cells and the immunopathogenesis of systemic lupus erythematosus. Immunologic Research 37:2, pages 135-145.
Crossref
Crossref
Sean R. Christensen & Mark J. Shlomchik. (2007) Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors. Seminars in Immunology 19:1, pages 11-23.
Crossref
Crossref
Stergios J. Moschos & John M. Kirkwood. 2007. General Principles of Tumor Immunotherapy. General Principles of Tumor Immunotherapy
405
430
.
Jiankun Zhu & Chandra Mohan. 2007. Immune-Mediated Diseases. Immune-Mediated Diseases
85
95
.
Ann Marshak-Rothstein. (2006) Toll-like receptors in systemic autoimmune disease. Nature Reviews Immunology 6:11, pages 823-835.
Crossref
Crossref
Kelly L. Summers, Annette M. Marleau, Jeffrey L. Mahon, Ruth McManus, Irene Hramiak & Bhagirath Singh. (2006) Reduced IFN-α secretion by blood dendritic cells in human diabetes. Clinical Immunology 121:1, pages 81-89.
Crossref
Crossref
Anthony Meager, Kumuthini Visvalingam, Pärt Peterson, Kaidi Möll, Astrid Murumägi, Kai Krohn, Petra Eskelin, Jaakko Perheentupa, Eystein Husebye, Yoshihisa Kadota & Nick Willcox. (2006) Anti-Interferon Autoantibodies in Autoimmune Polyendocrinopathy Syndrome Type 1. PLoS Medicine 3:7, pages e289.
Crossref
Crossref
Jing Hua, Kyriakos Kirou, Christina Lee & Mary K. Crow. (2006) Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti–RNA binding protein autoantibodies. Arthritis & Rheumatism 54:6, pages 1906-1916.
Crossref
Crossref
Gunnel Nordmark, Gunnar V Alm & Lars Rönnblom. (2006) Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system. Nature Clinical Practice Rheumatology 2:5, pages 262-269.
Crossref
Crossref
Kyriakos A. Kirou, Jane E. Salmon & Mary K. Crow. (2006) Soluble Mediators as Therapeutic Targets in Systemic Lupus Erythematosus: Cytokines, Immunoglobulin Receptors, and the Complement System. Rheumatic Disease Clinics of North America 32:1, pages 103-119.
Crossref
Crossref
Lars Rönnblom, Maija‐Leena Eloranta & Gunnar V. Alm. (2006) The type I interferon system in systemic lupus erythematosus. Arthritis & Rheumatism 54:2, pages 408-420.
Crossref
Crossref
Hermann Wagner. 2006.
159
173
.
Mary K. Crow. (2005) Interferon pathway activation in systemic lupus erythematosus. Current Rheumatology Reports 7:6, pages 463-468.
Crossref
Crossref
Chau-Ching Liu, Susan Manzi & Joseph M Ahearn. (2005) Biomarkers for systemic lupus erythematosus: a review and perspective. Current Opinion in Rheumatology 17:5, pages 543-549.
Crossref
Crossref
Frank O. Nestle, Curdin Conrad, Adrian Tun-Kyi, Bernhard Homey, Michael Gombert, Onur Boyman, Günter Burg, Yong-Jun Liu & Michel Gilliet. (2005) Plasmacytoid predendritic cells initiate psoriasis through interferon-α production. The Journal of Experimental Medicine 202:1, pages 135-143.
Crossref
Crossref
Argyrios N. TheofilopoulosRoberto BaccalaBruce BeutlerDwight H. Kono. (2005) TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY. Annual Review of Immunology 23:1, pages 307-335.
Crossref
Crossref
Roberto Baccala, Dwight H. Kono & Argyrios N. Theofilopoulos. (2005) Interferons as pathogenic effectors in autoimmunity. Immunological Reviews 204:1, pages 9-26.
Crossref
Crossref
Jean-François Bach. (2005) A Toll-like trigger for autoimmune disease. Nature Medicine 11:2, pages 120-121.
Crossref
Crossref
Cosimo TortorellaNicola NapoliElisabetta PanellaAlessandra AnotonaciAntonia GentileSalvatore Antonaci. (2004)
Asymptomatic Systemic Sarcoidosis Arising 5 Years After IFN-
α
Treatment for Chronic Hepatitis C: A New Challenge for Clinicians
. Journal of Interferon & Cytokine Research 24:11, pages 655-658.
Crossref
Crossref
Mary K Crow & Kyriakos A Kirou. (2004) Interferon-α in systemic lupus erythematosus. Current Opinion in Rheumatology 16:5, pages 541-547.
Crossref
Crossref